A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder

NCT00073203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

488

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: R228060
DRUG: Placebo and Paroxetine

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.